Cargando…
SAT463 Hormonal Contraceptive Use and Hypothyroidism Risk
Disclosure: S. Gloe: None. T.B. Carroll: Consulting Fee; Self; Corcept Therapeutics. Research Investigator; Self; Corcept Therapeutics, Novartis Pharmaceuticals. Introduction: Thyroid dysfunction is one of the most common endocrine disorders, with an estimated 4.3% of the US affected by subclinical...
Autores principales: | Gloe, Shawna, Carroll, Ty B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553720/ http://dx.doi.org/10.1210/jendso/bvad114.1937 |
Ejemplares similares
-
SAT-463 Thyrotoxicosis from Nivolumab in a Patient with Preexisting Graves’ Disease
por: Polavarapu, Preethi, et al.
Publicado: (2020) -
SAT-494 An Unusual Presentation of Hypothyroidism
por: Sukumaran, Anju
Publicado: (2020) -
SAT492 Hypothyroidism Induced Psychosis: A Rare Initial Presentation Of Severe Hypothyroidism
por: Shaukat, Mishal, et al.
Publicado: (2023) -
SAT505 Pericardial Effusion as The Primary Manifestation of Hypothyroidism
por: Lai, William, et al.
Publicado: (2023) -
SAT-622 Rhabdomyolysis: A Rare Initial Presentation of Hypothyroidism
por: Dhillon, Puneet, et al.
Publicado: (2019)